Acorah Software Products - Accounts Production 19.2.350 false true 31 May 2024 1 June 2023 false 1 June 2024 31 May 2025 31 May 2025 09608798 Mr K McArdle Mrs R McArdle iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 09608798 2024-05-31 09608798 2025-05-31 09608798 2024-06-01 2025-05-31 09608798 frs-core:ShareCapital 2025-05-31 09608798 frs-core:RetainedEarningsAccumulatedLosses 2025-05-31 09608798 frs-bus:PrivateLimitedCompanyLtd 2024-06-01 2025-05-31 09608798 frs-bus:FilletedAccounts 2024-06-01 2025-05-31 09608798 frs-bus:SmallEntities 2024-06-01 2025-05-31 09608798 frs-bus:AuditExempt-NoAccountantsReport 2024-06-01 2025-05-31 09608798 frs-bus:SmallCompaniesRegimeForAccounts 2024-06-01 2025-05-31 09608798 frs-bus:Director1 2024-06-01 2025-05-31 09608798 frs-bus:CompanySecretary1 2024-06-01 2025-05-31 09608798 frs-countries:EnglandWales 2024-06-01 2025-05-31 09608798 2023-05-31 09608798 2024-05-31 09608798 2023-06-01 2024-05-31 09608798 frs-core:ShareCapital 2024-05-31 09608798 frs-core:RetainedEarningsAccumulatedLosses 2024-05-31
Registered number: 09608798
Hazelwood Pharma Law Services Limited
Financial Statements
For The Year Ended 31 May 2025
BBK Partnership
Chartered Accountants & Statutory Auditors
1 Beauchamp Court, 10 Victors Way
Barnet
Hertfordshire
EN5 5TZ
Hazelwood Pharma Law Services Limited
Contents
Contents

| Page
--- | ---
Balance Sheet | 1—2
Notes to the Financial Statements | 3—4

Page 1
Hazelwood Pharma Law Services Limited
Balance Sheet
As At 31 May 2025
Balance Sheet
Registered number: 09608798

| 2025 | 2024
--- | --- | ---
| Notes | £ | £ | £ | £
CURRENT ASSETS
Debtors | 4 | 101 |  | 1,272 |
Cash at bank and in hand |  | 59,469 |  | 62,934 |
|  | 59,570 |  | 64,206 |
Creditors: Amounts Falling Due Within One Year | 5 | (1,178 ) |  | (2,705 ) |
NET CURRENT ASSETS (LIABILITIES) |  |  | 58,392 |  | 61,501
TOTAL ASSETS LESS CURRENT LIABILITIES |  |  | 58,392 |  | 61,501
NET ASSETS |  |  | 58,392 |  | 61,501
CAPITAL AND RESERVES
Called up share capital | 6 |  | 100 |  | 100
Profit and Loss Account |  |  | 58,292 |  | 61,401
SHAREHOLDERS' FUNDS |  |  | 58,392 |  | 61,501

Page 1
Page 2
Hazelwood Pharma Law Services Limited
Balance Sheet (continued)
As At 31 May 2025
For the year ending 31 May 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
The company has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the company's Profit and Loss Account.
On behalf of the board

Mr K McArdle Director
19/05/2026

The notes on pages 3 to 4 form part of these financial statements.
Page 2
Page 3
Hazelwood Pharma Law Services Limited
Notes to the Financial Statements
For The Year Ended 31 May 2025
Notes to the Financial Statements
1. General Information
Hazelwood Pharma Law Services Limited is a private company, limited by shares, incorporated in England & Wales, registered number 09608798 . The registered office is 1 Beauchamp Court, 10 Victors Way, Barnet, Hertfordshire, EN5 5TZ.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements have been prepared under the historical cost convention and in accordance with Financial Reporting Standard 102 section 1A Small Entities "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006.
2.2. Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the statement of comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The company's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
3. Average Number of Employees
Average number of employees, including directors, during the year was: 1 (2024: NIL)
1 -
4. Debtors

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Due within one year
Other debtors | 101 |  | 1,272

5. Creditors: Amounts Falling Due Within One Year

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Other creditors | 1,178 |  | 2,705

6. Share Capital

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
Allotted, Called up and fully paid | 100 |  | 100

Page 3
Page 4
Hazelwood Pharma Law Services Limited
Notes to the Financial Statements (continued)
For The Year Ended 31 May 2025
7. Dividends

| 2025 |  | 2024
--- | --- | --- | ---
| £ |  | £
On equity shares:
Final dividend paid | 500 |  | 500

Page 4